لخّصلي

The primary mechanism of betamethasone valerate is its ability to control inflammation.It inhibits the abnormal proliferation of keratinocytes, which are the predominant cells in the epidermis.Inflammation is a biological response to harmful stimuli such as pathogens, damaged cells, or irritants, and it involves the immune system's release of pro-inflammatory cytokines and mediators ,the drug penetrates the skin and binds to intracellular glucocorticoid receptors.betamethasone valerate reduces the recruitment and activation of inflammatory cells such as neutrophils, eosinophils, macrophages, and lymphocytes to the site of inflammation.

The primary mechanism of betamethasone valerate is its ability to control inflammation. Inflammation is a biological response to harmful stimuli such as pathogens, damaged cells, or irritants, and it involves the immune system's release of pro-inflammatory cytokines and mediators ,the drug penetrates the skin and binds to intracellular glucocorticoid receptors. This binding forms a receptor-steroid complex that translocates to the cell nucleus, where it interacts with specific DNA sequences known as glucocorticoid response elements (GREs).

betamethasone valerate reduces the recruitment and activation of inflammatory cells such as neutrophils, eosinophils, macrophages, and lymphocytes to the site of inflammation.

The drug decreases the function of immune cells, including T-cells and antigen-presenting cells like dendritic cells. It also inhibits the release of histamine and other substances from mast cells and basophils, reducing allergic responses and tissue swelling.

Additionally, betamethasone valerate exhibits antiproliferative properties. It inhibits the abnormal proliferation of keratinocytes, which are the predominant cells in the epidermis. This action is especially useful in treating conditions such as psoriasis, where rapid skin cell turnover leads to scaling and thickened plaques.